With the advent of whole slide digital scanners, histopathology slides can be digitized into very high-resolution digital images, realizing a new big data stream that can potentially rival omics data in size and complexity. Just as with the analysis of high-throughput genetic and expression data, the application of sophisticated image analytic tools and data pipelines can render the often passive data of digital pathology (DP) archives into a powerful source for: (a) rich quantitative insights into cancer biology and (b) companion diagnostic decision support tools for precision medicine. Digital pathology enabled companion diagnostic tests could yield predictions of cancer risk and aggressiveness in a manner similar to molecular diagnostic tests. However, prior to widespread clinical adoption of DP, extensive evaluation of clinical interpretation of DP imaging (DPI) and accompanying decision support tools needs to be undertaken. Wider acceptance of DPI by the cancer community (clinical and research) is hampered by lack of a publicly available, open access image informatics platform for easily viewing, managing, and quantitatively analyzing DPIs. While some commercial platforms exist for viewing and analyzing DPI data, none of these platforms are freely available. Open source image viewing/management platforms that cater to the radiology (e.g. XNAT) and computational biology communities are typically not conducive to handling very large file sizes as encountered with DPI datasets. This multi-PI U24 proposal seeks to expand on an existing, freely available pathology image viewer (Sedeen Image Viewer) to create a pathology informatics platform (PIIP) for managing, annotating, sharing, and quantitatively analyzing DPI data. Sedeen was designed as a universal platform for DPI (by addressing several proprietary scanner formats and big data challenges), to provide (1) reliable and useful image annotation tools, and (2) for image registration and analysis of DPI data. Additionally, Sedeen has become an application for cropping large DPIs so that they can be input into programs such as Matlab or ImageJ. Sedeen has been freely available to the public for three years, with over 160 unique users from over 20 countries. Building on the initial successes of Sedeen and its existing user base, our intent is to massively increase dissemination of DPI and algorithms in the cancer research community and clinical trial efforts, as well as to contribute towards the adoption of a rational and standardized set of DP operational conventions. This unique project will allow end users with different needs and technical backgrounds to seamlessly (a) archive and manage, (b) share, and (c) visualize their DPI data, acquired from different sites, formats, and platforms. The PIIP will provide a unified user interface for third party algorithms (nuclear segmentation, color normalization, biomarker quantification, radiology-pathology fusion) and will allow for algorithmic evaluation upon data arising from a plurality of source sites. By partnering with professional societies, we envision that the PIIP user base will expand to include the oncology, pathology, radiology, and pharmaceutical communities.

Public Health Relevance

This grant will result in the further development of advanced functionality of the already existing digital pathology image informatics platform (PIIP) with an established user-base for cancer research. Such an enhanced platform will provide the much-needed foundation for advancing (a) routine clinical adoption of digital pathology for primary diagnosis and (b) training and validation of companion diagnostic decision support systems based off histopathology. Thus, the project is aligned with the NCI's goal to foster innovative research strategies and their applications as a basis for ultimately protecting and improving human health.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
1U24CA199374-01
Application #
8970326
Study Section
Special Emphasis Panel (ZCA1-TCRB-W (M1))
Program Officer
Ossandon, Miguel
Project Start
2015-09-17
Project End
2020-08-31
Budget Start
2015-09-17
Budget End
2016-08-31
Support Year
1
Fiscal Year
2015
Total Cost
$606,305
Indirect Cost
$116,851
Name
Case Western Reserve University
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Abdul-Wahid, Aws; Cydzik, Marzena; Fischer, Nicholas W et al. (2018) Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. Int J Cancer 143:1963-1977
Millikin, Robert J; Solntsev, Stefan K; Shortreed, Michael R et al. (2018) Ultrafast Peptide Label-Free Quantification with FlashLFQ. J Proteome Res 17:386-391
Carleton, Neil M; Lee, George; Madabhushi, Anant et al. (2018) Advances in the computational and molecular understanding of the prostate cancer cell nucleus. J Cell Biochem 119:7127-7142
Alilou, Mehdi; Orooji, Mahdi; Beig, Niha et al. (2018) Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas. Sci Rep 8:15290
Niazi, Muhammad Khalid Khan; Senaras, Caglar; Pennell, Michael et al. (2018) Relationship between the Ki67 index and its area based approximation in breast cancer. BMC Cancer 18:867
Antunes, Jacob; Viswanath, Satish; Brady, Justin T et al. (2018) Coregistration of Preoperative MRI with Ex Vivo Mesorectal Pathology Specimens to Spatially Map Post-treatment Changes in Rectal Cancer Onto In Vivo Imaging: Preliminary Findings. Acad Radiol 25:833-841
Janowczyk, Andrew; Doyle, Scott; Gilmore, Hannah et al. (2018) A resolution adaptive deep hierarchical (RADHicaL) learning scheme applied to nuclear segmentation of digital pathology images. Comput Methods Biomech Biomed Eng Imaging Vis 6:270-276
Leo, Patrick; Elliott, Robin; Shih, Natalie N C et al. (2018) Stable and discriminating features are predictive of cancer presence and Gleason grade in radical prostatectomy specimens: a multi-site study. Sci Rep 8:14918
Lu, Cheng; Romo-Bucheli, David; Wang, Xiangxue et al. (2018) Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers. Lab Invest 98:1438-1448
Beig, Niha; Patel, Jay; Prasanna, Prateek et al. (2018) Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma. Sci Rep 8:7

Showing the most recent 10 out of 61 publications